EP1019041A4 - Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains - Google Patents

Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Info

Publication number: EP1019041A4
Authority: EP; European Patent Office
Prior art keywords: mood; stimulating; humans; disturbed behavior; improving
Prior art date: 1997-05-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98920311A

Other languages

German (de)

English (en)

Other versions

EP1019041A1 (fr

Inventor

Ladislav Volicer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Unimed Pharmaceuticals LLC

Original Assignee

Unimed Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-07

Filing date

1998-05-06

Publication date

2002-04-17

1997-05-30 Priority claimed from US08/866,511 external-priority patent/US5804592A/en

1998-05-06 Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC

2000-07-19 Publication of EP1019041A1 publication Critical patent/EP1019041A1/fr

2002-04-17 Publication of EP1019041A4 publication Critical patent/EP1019041A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP98920311A 1997-05-07 1998-05-06 Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains Withdrawn EP1019041A4 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4581397P	1997-05-07	1997-05-07
US45813P		1997-05-07
US866511		1997-05-30
US08/866,511 US5804592A (en)	1997-05-30	1997-05-30	Method for improving disturbed behavior and elevating mood in humans
PCT/US1998/009269 WO1998050027A1 (fr)	1997-05-07	1998-05-06	Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Publications (2)

Publication Number	Publication Date
EP1019041A1 EP1019041A1 (fr)	2000-07-19
EP1019041A4 true EP1019041A4 (fr)	2002-04-17

Family

ID=26723227

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98920311A Withdrawn EP1019041A4 (fr)	1997-05-07	1998-05-06	Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Country Status (6)

Country	Link
EP (1)	EP1019041A4 (fr)
JP (1)	JP2002501510A (fr)
AU (1)	AU743788B2 (fr)
CA (1)	CA2288693A1 (fr)
IL (1)	IL132784A (fr)
WO (1)	WO1998050027A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
BR112020019768A2 (pt)	2018-03-30	2021-01-26	India Globalization Capital, Inc.	método e composição para o tratamento de distúrbios do sistema nervoso central (snc)
KR20220009954A (ko)	2019-04-17	2022-01-25	컴퍼스 패쓰파인더 리미티드	신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0427518A1 (fr) *	1989-11-07	1991-05-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Composés de NMDA-blocage, compositions pharmaceutiques, leur préparation et leur usage
WO1995020958A1 (fr) *	1994-02-07	1995-08-10	Ramot University Authority For Applied Research And Industrial Development Ltd.	Derives de dexanabinol et leur emploi en tant que compositions pharmaceutiques neuroprotectrices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5596106A (en) *	1994-07-15	1997-01-21	Eli Lilly And Company	Cannabinoid receptor antagonists

1998
- 1998-05-06 EP EP98920311A patent/EP1019041A4/fr not_active Withdrawn
- 1998-05-06 IL IL13278498A patent/IL132784A/en not_active IP Right Cessation
- 1998-05-06 CA CA002288693A patent/CA2288693A1/fr not_active Abandoned
- 1998-05-06 AU AU72916/98A patent/AU743788B2/en not_active Ceased
- 1998-05-06 WO PCT/US1998/009269 patent/WO1998050027A1/fr not_active Ceased
- 1998-05-06 JP JP54846498A patent/JP2002501510A/ja not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0427518A1 (fr) *	1989-11-07	1991-05-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Composés de NMDA-blocage, compositions pharmaceutiques, leur préparation et leur usage
WO1995020958A1 (fr) *	1994-02-07	1995-08-10	Ramot University Authority For Applied Research And Industrial Development Ltd.	Derives de dexanabinol et leur emploi en tant que compositions pharmaceutiques neuroprotectrices

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Study finds Dronabinol promising in Alzheimer disease", JOURNAL OF PHARMACY TECHNOLOGY, CINCINNATI, OH, US, vol. 12, no. 6, November 1996 (1996-11-01), pages 294, XP002114257, ISSN: 8755-1225 *
RUPNIAK ET AL.: "Induction of cognitive impairment by scopolamine and noncholinergic agents in Rhesus monkeys", LIFE SCIENCES, vol. 48, no. 9, 1991, pages 893 - 899, XP008000795 *
See also references of WO9850027A1 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", INT. J. GERIATRIC PSY., vol. 12, no. 9, September 1997 (1997-09-01), pages 913 - 919, XP008000789 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", NEUROBIOLOGY OF AGING, vol. 17, no. 4supl., 1996, pages s73 - s74, XP008000790 *
VOLICER L: "Dronabinol may help behavior problems in Alzheimer's disease", AMERICAN FAMILY PHYSICIAN, AMERICAN ACADEMY OF FAMILY PHYSICIANS, US, vol. 55, no. 4, March 1997 (1997-03-01), pages 1338, XP002114258 *

Also Published As

Publication number	Publication date
IL132784A0 (en)	2001-03-19
AU7291698A (en)	1998-11-27
WO1998050027A1 (fr)	1998-11-12
EP1019041A1 (fr)	2000-07-19
JP2002501510A (ja)	2002-01-15
CA2288693A1 (fr)	1998-11-12
AU743788B2 (en)	2002-02-07
IL132784A (en)	2004-07-25

Similar Documents

Publication	Publication Date	Title
HUP0103114A3 (en)	2003-09-29	Apolipoprotein a-1 agonists and their use to treat dyslipidemic disorders
EP0837669A4 (fr)	2001-01-24	Procede et composition contre le tartre dentaire chez les animaux domestiques
EP0784464A4 (fr)	1999-03-24	Composition et procede de traitement capillaire
FI972093A7 (fi)	1997-07-02	Jäteveden käsittelymenetelmä ja -laitos
BR9609132A (pt)	1999-08-17	Composicão e método de tratamento de semente
DE69838374D1 (de)	2007-10-18	Prozessor und Verfahren zum Verringern von dessen Energieverbrauch
DE59500879D1 (de)	1997-12-04	Mittel zur Wasserbehandlung mit Polyasparaginsäure oder einem Derivat davon und Phosphonsäure
HUP0003924A3 (en)	2005-12-28	Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
IL122684A0 (en)	1998-08-16	Method for cleaning and reducing the level of microorganisms in edible animal protein
EE9900421A (et)	2000-04-17	Koduse olmeheitvee puhastussüsteem ja meetod
DE69630947D1 (de)	2004-01-15	Mittel zur schmerzbehandlung
IL121268A0 (en)	1998-01-04	Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
EP1014972A4 (fr)	2004-12-08	Procede de traitement et composition pharmaceutique
EP0954212A4 (fr)	2003-04-02	Procede et appareil d'alimentation en composants
FI963099A7 (fi)	1996-08-07	Vedenkäsittelymenetelmä ja -laite
FR2746681B1 (fr)	2001-02-02	Procede et appareil d'alimentation en pieces longues
FR2772142B1 (fr)	2001-11-09	Procede de traitement antireflet et materiau presentant des proprietes antireflet
EP0808563A4 (fr)	2000-10-11	Materiau de traitement pour excrements d'animaux et procede de production de ce materiau
EP1019041A4 (fr)	2002-04-17	Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains
IL126113A0 (en)	1999-05-09	Methods for treatment of allergic diseases with ige
FR2731289B1 (fr)	1997-05-23	Procede et dispositif d'amelioration de la securite des etres vivants et plus particulierement des personnes
HUP0004372A3 (en)	2002-10-28	Water treatment method and device
AU5388299A (en)	2000-03-06	Antibodies for use in targeted and temporary treatment of humans and animals
BA98363A (bs)	2001-09-14	Postupak i uredaj za tretiranje koze i tome slicno
BR9708351A (pt)	1999-08-03	Métodos de tratamento de picadas e mordidas venenosas

Legal Events

Date	Code	Title	Description
2000-06-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-07-19	17P	Request for examination filed	Effective date: 19991207
2000-07-19	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-04-17	A4	Supplementary search report drawn up and despatched	Effective date: 20020305
2002-04-17	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-11-20	17Q	First examination report despatched	Effective date: 20021007
2006-12-13	17Q	First examination report despatched	Effective date: 20021007
2007-10-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2007-11-28	18D	Application deemed to be withdrawn	Effective date: 20070519